Cefpodoxime Proxetil
In Stock•Starting at $8 for 1 mg•Purity ≥ 95%
| CAS No. | 87239-81-4 |
|---|---|
| MDL No. | MFCD00865088 |
| MF | C21H27N5O9S2 |
| MW | 557.60 |
| InChI Key | LTINZAODLRIQIX-FBXRGJNPSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 95% | $8 | In Stock | |
| 5 mg | 95% | $9 | In Stock | |
| 25 mg | 95% | $10 | In Stock | |
| 250 mg | 95% | $13 | In Stock | |
| 1 g | 95% | $22 | In Stock |
Product Information
Cefpodoxime proxetil is the 1-[(isopropoxycarbonyl)oxy]ethyl (proxetil) ester prodrug of cefpodoxime. Upon ingestion, the ester group is hydrolyzed in the intestinal epithelium, releasing active cefpodoxime into the bloodstream. It is used to treat acute otitis media, pharyngitis, and sinusitis. It functions as a prodrug and an antibacterial agent. It is a carboxylic ester, a cephalosporin, and a carboxylic acid. It is functionally related to cefpodoxime and a 4-{((R)-2-Carboxy-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-7-ylcarbamoyl)-[(Z)-methoxyimino]-methyl}-thiazol-2-yl-ammonium.
| CAS No. | 87239-81-4 |
|---|---|
| Product Name | Cefpodoxime Proxetil |
Associated Conditions
Otitis media·osteomyelitis
* The information provided here is compiled from public sources and is for reference only.
